Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy

Chemico-Biological Interactions

Volumn 223, Issue , 2014, Pages 125-133

  Kumar, Goru Santosh ^a   Kulkarni, Apoorva ^a   Khurana, Amit ^a   Kaur, Jasmine ^a   Tikoo, Kulbhushan ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Apoptosis; Diabetic nephropathy; HSP 70; Selenium nanoparticles

Indexed keywords

ALBUMIN; COLLAGEN; CREATININE; FIBRONECTIN; HEAT SHOCK PROTEIN 70; PROTEIN BAX; PROTEIN BCL 2; SELENIUM DERIVATIVE; SELENIUM NANOPARTICLE; SIRTUIN 1; UNCLASSIFIED DRUG; BAX PROTEIN, RAT; COLLAGEN TYPE 4; NANOPARTICLE; SELENIUM; SIRT1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG MECHANISM; HISTOPATHOLOGY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; ANIMAL; APOPTOSIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DRUG EFFECTS; KIDNEY; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; COLLAGEN TYPE IV; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FIBRONECTINS; HSP70 HEAT-SHOCK PROTEINS; KIDNEY; MALE; NANOPARTICLES; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; SIRTUIN 1;

EID: 84908461327     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.09.017     Document Type: Article

References (55)

1. B. Najafian, M. Mauer, Progression of diabetic nephropathy in type 1 diabetic patients, Diabetes Res. Clin. Pract. 83 (2009) 1-8.
2. K. Ichinose, Y. Maeshima, Y. Yamamoto, H. Kitayama, Y. Takazawa, K. Hirokoshi, H. Sugiyama, Y. Yamasaki, K. Eguchi, H. Makino, Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model, Diabetes 54 (2005) 2891-2903.
3. Y.S. Kanwar, J. Wada, L. Sun, P. Xie, E.I. Wallner, S. Chen, S. Chugh, F.R. Danesh, Diabetic nephropathy: mechanisms of renal disease progression, Exp. Biol. Med. 233 (2008) 4-11.
4. T. Jiang, Z. Huang, Y. Lin, Z. Zhang, D. Fang, D.D. Zhang, The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy, Diabetes 59 (2010) 850-860.
5. Y.S. Kanwar, L. Sun, P. Xie, F.-Y. Liu, S. Chen, A glimpse of various pathogenetic mechanisms of diabetic nephropathy, Annu. Rev. Pathol. 6 (2011) 395-423.
6. G.G. Wang, X.H. Lu, W. Li, X. Zhao, C. Zhang, Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats, Evid Based Complement Altern. Med. 2011 (2011) 323171.
7. A.A. Eid, B.M. Ford, K. Block, B.S. Kasinath, Y. Gorin, G. Ghosh-Choudhury, J.L. Barnes, H.E. Abboud, AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes, J. Biol. Chem. 285 (2010) 37503-37512.
8. F. Wagener, D. Dekker, J.H. Berden, A. Scharstuhl, J. Van Der Vlag, The role of reactive oxygen species in apoptosis of the diabetic kidney, Apoptosis 14 (2009) 1451-1458.
9. J. Das, V. Vasan, P.C. Sil, Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis, Toxicol. Appl. Pharmacol. 258 (2012) 296-308.
10. M. Naziroʇlu, M. Cay, Protective role of intraperitoneally administered vitamin E and selenium on the antioxidative defense mechanisms in rats with diabetes induced by streptozotocin, Biol. Trace Elem. Res. 79 (2001) 149-159.
11. S.S. Chung, M. Kim, B.-S. Youn, N.S. Lee, J.W. Park, I.K. Lee, Y.S. Lee, J.B. Kim, Y.M. Cho, H.K. Lee, Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells, Mol. Cell. Biol. 29 (2009) 20-30.
12. A. Takeyama, H. Sato, T. Soma-Nagae, H. Kabasawa, A. Suzuki, K. Yamamoto-Kabasawa, M. Hosojima, R. Kaneko, F. Higuchi, R. Kaseda, Megalin is downregulated via LPS-TNF-α-ERK1/2 signaling pathway in proximal tubule cells, Biochem. Biophys. Res. Commun. 407 (2011) 108-112.
13. M. Navarro-Alarcón, M.C. López-Martínez, Essentiality of selenium in the human body: relationship with different diseases, Sci. Total Environ. 249 (2000) 347-371.
14. M. Ayaz, H.A. Celik, H.H. Aydin, B. Turan, Sodium selenite protects against diabetes-induced alterations in the antioxidant defense system of the liver, Diabetes Metab. Res. Rev. 22 (2006) 295-299.
15. P. Chew, D.Y.C. Yuen, N. Stefanovic, J. Pete, M.T. Coughlan, K.A. Jandeleit-Dahm, M.C. Thomas, F. Rosenfeldt, M.E. Cooper, J.B. de Haan, Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse, Diabetes 59 (2010) 3198-3207.
16. T. Chen, Y.-S. Wong, W. Zheng, Y. Bai, L. Huang, Selenium nanoparticles fabricated in Undaria pinnatifida polysaccharide solutions induce mitochondria-mediated apoptosis in A375 human melanoma cells, Colloids Surf., B 67 (2008) 26-31.
17. K.M. Hassanin, S.H.A. El-Kawi, K.S. Hashem, The prospective protective effect of selenium nanoparticles against chromium-induced oxidative and cellular damage in rat thyroid, Int. J. Nanomed. 8 (2013) 1713-1720.
18. Q. Chen, Z. Wang, Y. Xiong, W. Xue, X. Kao, Y. Gao, N. Muhammad, D. Song, Selenium increases expression of HSP70 and antioxidant enzymes to lessen oxidative damage in Fincoal-type fluorosis, J. Toxicol. Sci. 34 (2009) 399-405.
19. S. Yousuf, F. Atif, M. Ahmad, M. Nasrul Hoda, M. Badruzzaman Khan, T. Ishrat, F. Islam, Selenium plays a modulatory role against cerebral ischemia-induced neuronal damage in rat hippocampus, Brain Res. 1147 (2007) 218-225.
20. J.L. Martindale, N.J. Holbrook, Cellular response to oxidative stress: signaling for suicide and survival, J. Cell. Physiol. 192 (2002) 1-15.
21. K.K. Vekariya, J. Kaur, K. Tikoo, ERα signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer, Nanomed: NBM 8 (2012) 1125-1132.
22. K. Tikoo, D.N. Tripathi, D.G. Kabra, V. Sharma, A.B. Gaikwad, Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53, FEBS Lett. 581 (2007) 1071-1078.
23. U.M. Mahajan, C. Gupta, P.R. Wagh, P.A. Karpe, K. Tikoo, Alteration in inflammatory/apoptotic pathway and histone modifications by nordihydroguaiaretic acid prevents acute pancreatitis in swiss albino mice, Apoptosis 16 (2011) 1138-1149.
24. P.K. Dabla, Renal function in diabetic nephropathy, World J. Diabetes 1 (2010) 48-56.
25. T. Nakagawa, W. Sato, O. Glushakova, M. Heinig, T. Clarke, M. Campbell-Thompson, Y. Yuzawa, M.A. Atkinson, R.J. Johnson, B. Croker, Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy, J. Am. Soc. Nephrol. 18 (2007) 539-550.
26. H. Makino, H. Sugiyama, N. Kashihara, Apoptosis and extracellular matrix-cell interactions in kidney disease, Kidney Int. 58 (2000) S67-S75.
27. H.M. Beere, Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways, J. Clin. Invest. 115 (2005) 2633-2639.
28. K. Tikoo, K. Singh, D. Kabra, V. Sharma, A. Gaikwad, Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy, Free Radical Biol. Res. 42 (2008) 397-404.
29. M. Kitada, S. Kume, N. Imaizumi, D. Koya, Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway, Diabetes 60 (2011) 634-643.
30. D. Verzola, M.B. Bertolotto, B. Villaggio, L. Ottonello, F. Dallegri, F. Salvatore, V. Berruti, M.T. Gandolfo, G. Garibotto, G. Deferrari, Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells, J. Am. Soc. Nephrol. 15 (2004) S85-S87.
31. Y.J. Kim, Y.A. Kim, T. Yokozawa, Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin, J. Agric. Food Chem. 57 (2009) 8793-8797.
32. D.-S. Jung, S.H. Lee, S.-J. Kwak, J.J. Li, B.-Y. Nam, H.Y. Kang, T.I. Chang, J.T. Park, S.H. Han, T.-H. Yoo, Apoptosis occurs differentially according to glomerular size in diabetic kidney disease, Nephrol. Dial. Transplant. 27 (2012) 259-266.
33. J.M. Forbes, M.T. Coughlan, M.E. Cooper, Oxidative stress as a major culprit in kidney disease in diabetes, Diabetes 57 (2008) 1446-1454.
34. M. Satoh, S. Fujimoto, Y. Haruna, S. Arakawa, H. Horike, N. Komai, T. Sasaki, K. Tsujioka, H. Makino, N. Kashihara, NAD (P) H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy, Am. J. Physiol. 288 (2005) F1144-F1152.
35. P.J. Beisswenger, K.S. Drummond, R.G. Nelson, S.K. Howell, B.S. Szwergold, M. Mauer, Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress, Diabetes 54 (2005) 3274-3281.
36. D. Koya, K. Hayashi, M. Kitada, A. Kashiwagi, R. Kikkawa, M. Haneda, Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats, J. Am. Soc. Nephrol. 14 (2003) S250-S253.
37. P. Faure, Protective effects of antioxidant micronutrients (vitamin E, zinc and selenium) in type 2 diabetes mellitus, Clin. Chem. Lab. Med. 41 (2003) 995-998.
38. C. Douillet, A. Tabib, M. Bost, M. Accominotti, F. Borson-Chazot, M. Ciavatti, Selenium in diabetes: effects of selenium on nephropathy in type I streptozotocin-induced diabetic rats, J. Trace Elem. Exp. Med. 12 (1999) 379-392.
39. P. Brenneisen, H. Steinbrenner, H. Sies, Selenium, oxidative stress, and health aspects, Mol. Aspects Med. 26 (2005) 256-267.
40. A.S. Reddi, J.S. Bollineni, Selenium-deficient diet induces renal oxidative stress and injury via TGF-&bgr; 1 in normal and diabetic rats, Kidney Int. 59 (2001) 1342-1353.
41. M. Ayaz, B. Turan, Selenium prevents diabetes-induced alterations in [Zn2+] i and metallothionein level of rat heart via restoration of cell redox cycle, Am. J. Physiol.-Heart Circulatory Physiol. 290 (2006) H1071-H1080.
42. L.M. Greggi Antunes, Darin J.D., M.d.L.P. Bianchi, Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats, Pharmacol. Res. 43 (2001) 145-150.
43. K.K. Vekariya, J. Kaur, K. Tikoo, Alleviating anastrozole induced bone toxicity by selenium nanoparticles in SD rats, Toxicol. Appl. Pharmacol. 268 (2013) 212-220.
44. X. Jia, N. Li, J. Chen, A subchronic toxicity study of elemental Nano-Se in Sprague-Dawley rats, Life Sci. 76 (2005) 1989-2003.
45. N. Ismail, B. Becker, P. Strzelczyk, E. Ritz, Renal disease and hypertension in non-insulin-dependent diabetes mellitus, Kidney Int. 55 (1999) 1-28.
46. L.E. Fridlyand, L.H. Philipson, Oxidative reactive species in cell injury: mechanisms in diabetes mellitus and therapeutic approaches, Ann. N. Y. Acad. Sci. 1066 (2006) 136-151.
47. V. Wiwanitkit, Diabetic nephropathy without hyperglycemia, Diabetes Metab. Syndrome: Clin. Res. Rev. 3 (2009) 118-119.
48. H. Ha, H.B. Lee, Reactive oxygen species and matrix remodeling in diabetic kidney, J. Am. Soc. Nephrol. 14 (2003) S246-S249.
49. S.M. Honorè, W.M. Cabrera, S.B. Genta, S.S. Sánchez, Protective effect of Yacon leaves decoction against early nephropathy in experimental diabetic rats, Food Chem. Toxicol. 50 (2012) 1704-1715.
50. T. Shinohara, N. Takahashi, T. Ooie, M. Hara, S. Shigematsu, M. Nakagawa, H. Yonemochi, T. Saikawa, H. Yoshimatsu, Phosphatidylinositol 3-kinase-dependent activation of Akt, an essential signal for hyperthermia-induced heat-shock protein 72, Is attenuated in streptozotocin-induced diabetic heart, Diabetes 55 (2006) 1307-1315.
51. H.M. Beere, B.B. Wolf, K. Cain, D.D. Mosser, A. Mahboubi, T. Kuwana, P. Tailor, R.I. Morimoto, G.M. Cohen, D.R. Green, Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome, Nat. Cell Biol. 2 (2000) 469-475.
52. S.D. Westerheide, J. Anckar, S.M. Stevens, L. Sistonen, R.I. Morimoto, Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1, Science 323 (2009) 1063-1066.
53. Y. Xu, L. Nie, Y.-G. Yin, J.-L. Tang, J.-Y. Zhou, D.-D. Li, S.-W. Zhou, Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells, Toxicol. Appl. Pharmacol. 259 (2012) 395-401.
54. M.-L. Brezniceanu, C.J. Lau, N. Godin, I. Chènier, A. Duclos, J. Ethier, J.G. Filep, J.R. Ingelfinger, S.-L. Zhang, J.S.D. Chan, Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy, J. Am. Soc. Nephrol. 21 (2010) 943-954.
55. S. Roy, S.K. Dontamalla, A.K. Mondru, S. Sannigrahi, P.R. Veerareddy, Downregulation of apoptosis and modulation of TGF-β by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment, Biol. Trace Elem. Res. 139 (2011) 55-71.